Description
ACAMPROSATE CA 333MG BENZOYL PEROXIDE 10% LOTION BACITRACIN 500/POLYMYXIN 10000/GM OINT 30GM CORTISONE ACETATE 25MG TAB DAPSONE 25MG TAB DILTIAZEM HCL 90MG 12HR CAP SA GLUCOSE 4GM CHEW TAB 50CT HYDROCORTISONE 1% LOTION 120ML NITROGLYCERIN 0.08MG/HR PATCH 30CT BATH POWDER OATMEAL COLLOIDIAL 100%
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-04-10+$47,816= $47,816
- Mod P000012015-10-05-$210= $47,605
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-04-10 | +$47,816 | $47,816 | ACAMPROSATE CA 333MG BENZOYL PEROXIDE 10% LOTION BACITRACIN 500/POLYMYXIN 10000/GM OINT 30GM CORTISONE ACETATE… |
| Mod P00001· FUNDING ONLY ACTION | 2015-10-05 | −$210 | $47,605 | ACAMPROSATE CA 333MG BENZOYL PEROXIDE 10% LOTION BACITRACIN 500/POLYMYXIN 10000/GM OINT 30GM CORTISONE ACETATE… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI M6CNG4Z6SPD8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77026P0088 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $90,636 | FY2026 |
| 36C26126N0155 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $650,000 | FY2026 |
| 36C26126D0008 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $0 | FY2026 |
| 36C77025P0209 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $90,472 | FY2025 |
| 36C77025P0106 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $12,131 | FY2025 |
| 36C77025P0075 | NATIONAL CMOP OFFICE (36C770) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $31,637 | FY2025 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (NCO) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA77016P0844 | ROCHE DIABETES CARE INC | NATIONAL CMOP OFFICE (NCO) | $494,384 | FY2016 |
| VA77016P0843 | D & H WHOLESALE MEDICAL, INC. | NATIONAL CMOP OFFICE (NCO) | $30,360 | FY2016 |
| VA77016P0828 | WESTMINSTER PHARMACEUTICALS, LLC | NATIONAL CMOP OFFICE (NCO) | $24,615 | FY2016 |
| VA77016E0865 | SOUND PACKAGING LLC | NATIONAL CMOP OFFICE (NCO) | $11,462 | FY2016 |
| VA77016E0862 | 3M COMPANY | NATIONAL CMOP OFFICE (NCO) | $9,177 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA77015P0294_3600_-NONE-_-NONE- · retrieved 2026-09-26.